Create a free Healthcare Packaging account to continue reading

Recipharm Connects to European Hub for Serialization Compliance

Recipharm’s three-year serialization program began in January 2016 and involves a 40-million-euro investment.

Stockholm-based Contract development and manufacturing organization (CDMO) Recipharm has received European Medicines Verification Organisation (EMVO) approval to submit serialization data to the European Hub.

The connection, facilitated by the company’ strategic partner TraceLink, represents a key milestone in Recipharm’s preparations for the Falsified Medicines Directive (FMD).